Faricimab for Treatment-Resistant Diabetic Macular Edema.

Published in: Clinical ophthalmology (Auckland, N.Z.) (2022)

For a significant minority, IVF can improve the short-term visual and anatomic outcomes in treatment-resistant DME patients formerly managed with IVA. Longer follow-up is needed to determine if such improvements can be preserved.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
metabolic syndrome